About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNCT06895187

Catheter Ablation Using a Novel Navigation and Imaging System

The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paro...

Lead sponsor: LUMA Vision Ltd.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Elke Sommerijns

CONTACT

+32479767156 elke.sommerijns@lumavision.com

Alisa Komleva

CONTACT

+353894352047 alisa.komleva@lumavision.com

Sponsors

Lead Sponsor

LUMA Vision Ltd.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subject is 18 years of age at the time of consent, or of legal age to give informed consent specific to state and national law
•Subjects is eligible for a catheter ablation procedure with the VERAFEYE System as navigation and imaging system in the treatment of PAF (according to VERAFEYE System IFUs, current international and local guidelines and per physician discretion)
•Subject is able to understand and willing to provide written informed consent
•Subject is able to and willing to complete all study assessments associated with this clinical study at an approved clinical investigational center

Related studies

Grid eXplore Mapping Study

NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)

Burst Stimulation for Paroxysmal Atrial Fibrillation

NCT07281898 · Paroxysmal Atrial Fibrillation

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

NCT05988411 · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

RECRUITINGPhase 4

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

NCT06765356 · Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, and more

VOLT CE Mark Study

NCT06106594 · Atrial Arrhythmia, Atrial Fibrillation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 10, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment100

Start dateOct 2026

Last updatedJun 10, 2026

Condition

Paroxysmal Atrial Fibrillation

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions